New Medical Horizons II, Ltd. – Trademark Portfolio

Entity Type: 13

New Medical Horizons II, Ltd. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 14 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CYPRESS FAIRBANKS OCCUPATIONAL MEDICINEA PART OF CY-FAIR REGIONAL HEALTH NETWORK. The owner is based in Dallas, TX.

1445 Ross Avenue, Suite 1400

Dallas, TX 752022703

14 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

New Medical Horizons II, Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (14 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does New Medical Horizons II, Ltd. have?

New Medical Horizons II, Ltd. has 14 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 11 cancelled.

What trademark classes does New Medical Horizons II, Ltd. file in?

New Medical Horizons II, Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are New Medical Horizons II, Ltd.'s most well-known trademarks?

New Medical Horizons II, Ltd.'s registered trademark portfolio includes well-known marks such as CYPRESS FAIRBANKS OCCUPATIONAL MEDICINEA PART OF CY-FAIR REGIONAL HEALTH NETWORK. These are among 1 currently registered trademark in the portfolio.

What is New Medical Horizons II, Ltd.'s trademark registration success rate?

New Medical Horizons II, Ltd. has a 7% trademark registration rate, with 1 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.